A detailed history of Greenspring Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Greenspring Advisors, LLC holds 2,586 shares of ABBV stock, worth $473,444. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,586
Holding current value
$473,444
% of portfolio
0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $423,690 - $515,467
2,586 New
2,586 $510,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $6,507 - $7,494
-45 Reduced 2.84%
1,541 $245,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $414 - $497
3 Added 0.19%
1,586 $256,000
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $212,454 - $243,671
1,583 New
1,583 $213,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Greenspring Advisors, LLC Portfolio

Follow Greenspring Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenspring Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenspring Advisors, LLC with notifications on news.